Prior Authorization Fixes Earn Majority Support in Congress
A majority of U.S. House members — 135 Democrats and 86 Republicans — co-sponsored the Improving Seniors' Timely Access to Care Act, with support from 450+ healthcare organizations.
Read the original article at American Medical AssociationAuthAnnie's Take
Our perspective on this story
By October 2024, the Improving Seniors' Timely Access to Care Act had earned something unusual in contemporary Congress: genuine majority support. With 221 co-sponsors in the House — 135 Democrats and 86 Republicans — the bill had crossed the threshold where it could theoretically pass on a floor vote. Support from over 450 healthcare organizations, including the AMA, AHA, and dozens of specialty societies, made it one of the most broadly endorsed healthcare bills in the session. For physician practices that have spent years advocating for prior authorization reform, this level of congressional support marks a tangible shift in the political landscape.
What Majority Support Actually Means
Having 221 co-sponsors in a 435-member House is significant, but congressional dynamics are more complex than simple vote counts. Committee scheduling, floor time allocation, Senate action, and legislative packaging all influence whether a bill with majority support actually becomes law. Bills with strong bipartisan co-sponsorship can still stall if leadership does not prioritize them or if they become entangled in unrelated legislative negotiations.
That said, the scale of co-sponsorship creates political pressure that is difficult to ignore. When a majority of the House has publicly endorsed a specific policy position, it signals to party leadership that the issue has broad electoral support. It also makes it easier to incorporate PA reform provisions into larger healthcare or spending bills as amendments or riders, even if the standalone bill does not advance.
Why This Coalition Formed
The breadth of the supporting coalition is worth examining because it reveals why PA reform has become politically viable:
- Physician organizations have documented the clinical burden with data — the AMA's survey finding 93% of physicians report PA-related care delays gives legislators a patient safety narrative
- Hospital systems have quantified the economic cost — $20 billion annually in denial management appeals provides a healthcare cost argument
- Patient advocacy groups have shared stories of treatment delays and adverse outcomes, creating constituent pressure on individual members
- Employer groups increasingly recognize that PA inefficiency drives up the administrative costs embedded in their health insurance premiums
This is not a single-interest bill. It addresses concerns spanning clinical, economic, and patient experience dimensions — a combination that creates durable political support.
Implications for Practices
Congressional momentum on PA reform creates a policy environment where practices' investments in denial management infrastructure become more valuable over time, not less. As federal requirements tighten PA processes, practices with systematic workflows will be positioned to hold payers accountable to new standards. Without those workflows, new regulations are just words on paper.
Consider what the bill's transparency provisions would mean in practice: if MA plans are required to report PA denial rates publicly, practices could benchmark their own denial experience against the reported rates. If your practice's denial rate with a specific MA plan significantly exceeds the plan's reported average, that discrepancy becomes a concrete data point for payer negotiations or regulatory complaints. But only if your practice tracks denial rates systematically.
The Broader Signal
The 221-co-sponsor milestone tells practices something important about the direction of healthcare policy: the political class has recognized that prior authorization, as currently practiced, is indefensible at scale. Whether this specific bill passes in this session or the next, the policy direction is set. Payers will face increasing federal and state requirements to speed up, standardize, and justify their PA processes. Every practice that builds systematic denial management capabilities today is building for an environment where those capabilities will have increasing leverage. The political momentum is not a reason to wait for reform. It is a reason to prepare for it.
More from the newsroom
Prior Authorization Reform Gains Momentum in States
Analysis of the accelerating pace of state prior authorization reform, including expanded gold-card programs, AI restrictions on coverage decisions, and mandatory decision timeframes.
Prior Authorization Gold Cards Might Need a New Prescription
Investigation into the implementation challenges of gold-card programs, including payer resistance and the need for legislative refinement as programs expand beyond Texas.
9 States Pass Bills to Fix Prior Authorization
Nine states enacted prior authorization reform legislation in 2024, addressing themes including gold-carding, response time requirements, and transparency mandates.